Clinical Trial Update: Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update describing the use of the cardioprotectant dexrazoxane during congenital heart surgery, with a proposal for a pilot investigation.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects

Drugs mentioned

• DEXRAZOXANE (DEXRAZOXANE)

Snippet

Sponsor: Medical City Children's Hospital | Conditions: Heart Defects, Congenital | Phase 1 | Status: TERMINATED